Latest antibodies Stories
BREDA, the Netherlands, GHENT, Belgium and WHITE PLAINS, New York, June 10, 2014 /PRNewswire/ -- arGEN-X, a clinical stage biopharmaceutical company focused on creating
MELBOURNE, Australia, June 5, 2014 /PRNewswire/ -- Nexvet Biopharma, a leading veterinary biologic drug developer, today announced the oral presentation of data related to clinical development of NV-01,
MUMBAI and LA CHAUX-DE-FONDS, Switzerland, June 4, 2014 /PRNewswire/ -- - State-of-the-art Manufacturing Facility for Supply of Clinical Trial Material -
BREDA, the Netherlands, June 4, 2014 /PRNewswire/ -- SIGNIFICANTLY EXPANDED RELATIONSHIP CREATED ON BACK OF COLLABORATION SUCCESS arGEN-X, a clinical-stage
LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
MONROVIA, Calif., May 28, 2014 /PRNewswire/ -- Xencor, Inc.
BREDA, The Netherlands, May 28, 2014 /PRNewswire/ -- arGEN-X, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies
Immunoglobulins or antibodies are proteins used by the immune system to neutralize pathogens including bacteria and viruses.
New research, by a team from Rhode Island Hospital (RIH), has uncovered a protein, or antigen, that is essential for malaria-causing parasites to escape from red blood cells. This protein also generates antibodies that can hinder the ability of malaria parasites to multiply, which may protect against severe malaria infection.
LONDON, May 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.
More Images (1 images) »